Spending on prescription medications under the 340B Drug Pricing Program grew more than fivefold from 2010 to 2021, according to a report the nonpartisan Congressional Budget Office.
Safety-net providers participating in 340B spent $43.9 billion on covered drugs in 2021, a 565% increase from $6.6 billion in 2010, the legislative branch agency reported. The findings are limited to the 90% of 340B providers that use the Health Resources and Services Administration’s Prime Vendor Program.
Click here to learn more.